Phase 2 Hepatitis B Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 to 64 years old, weighing between 45 and 150 kg, of any gender
- People who have been diagnosed with Chronic Hepatitis B
- People who are currently taking oral antiviral medication for their condition
- People whose liver enzyme levels (ALT and AST) are within an acceptable range, specifically no more than 1.5 times the upper limit of normal
- People whose total bilirubin level (a substance measured in blood tests) is within the normal range
Who may not be able to join:
- People who have significant scarring of the liver (fibrosis) or a condition called cirrhosis
- People who have, or have previously had, liver disease caused by something other than Hepatitis B
- There may be additional criteria not listed here that the trial site will assess (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: (617) 915 6203
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Safety and tolerability of single and multiple doses of CRMA-1001
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.